Bausch Health beats Q3 estimates; raises full-year guidance
Bausch Health Companies Inc. (NYSE: BHC) beat revenue and earnings expectations for the third quarter of 2019, allowing the shares...
Health Care
Allergan (AGN) Q3 earnings preview: Patent issues, AbbVie deal in focus
After securing shareholders’ approval for the takeover deal with AbbVie (ABBV), Allergan (NYSE: AGN) will be publishing its third-quarter results...
Immunogen Inc (NASDAQ:IMGN) Q3 2019 Earnings Call Transcript
Immunogen Inc (IMGN) Q3 2019 earnings call dated Nov 1, 2019 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and...
AbbVie (NYSE: ABBV) Q3 profit dips 31% but beats estimates
AbbVie Inc. (NYSE: ABBV) reported a 31% dip in earnings for the third quarter of 2019 due to higher costs...
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG): Q3 2019 Earnings Snapshot
— AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) reported a net loss of $23.62 million or $0.70 per share for the third...
Sanofi (NASDAQ: SNY): Q3 2019 Earnings Snapshot
— Generic drugmaker Sanofi (NASDAQ: SNY) reported net income of EUR 1.77 billion or EUR 1.49 per share for the...
Celgene (CELG) Q3 profit jumps 56% beats estimates
Celgene Corporation (NASDAQ: CELG) reported a 56% jump in earnings for the third quarter of 2019 helped by higher revenue...
Abiomed’s (ABMD) revenue increases 13% in Q2 on higher usage of Impella; reiterates 2020 outlook
Abiomed (NASDAQ: ABMD) reported a 13% growth in second quarter 2020 revenue, boosted by the increased usage of its Impella...
Bristol-Myers Squibb (BMY) earnings: Q3 results beat amid strong product sales
Driven by the strong sales of leading products, earnings of Bristol-Myers Squibb (NYSE: BMY) increased in the third quarter and...
Cigna (NYSE: CI): Q3 2019 Earnings Snapshot
— Cigna Corporation (NYSE: CI) reported its third-quarter 2019 adjusted operating earnings of $4.54 per share versus $4.36 per share...
ACADIA Pharmaceuticals (ACAD): Q3 2019 Earnings Snapshot
— ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) reported Q3 2019 loss of $0.29 per share, vs. $0.40 expected. — Revenues grew...
Vertex Pharmaceuticals (VRTX): Q3 2019 Earnings Snapshot
— Vertex Pharmaceuticals (NASDAQ: VRTX) reported third-quarter 2019 earnings of $1.23 per share, vs. $1.15 per share expected — Total...
Bristol-Myers (BMY) Q3 earnings preview: New indications, pipeline to bolster recovery
Bristol-Myers Squibb (NYSE: BMY) will be publishing its September-quarter earnings Thursday before the opening bell. The bio-pharmaceutical company is expected...
McKesson Corporation (MCK): Q3 2019 Earnings Snapshot
— McKesson Corporation (NYSE: MCK) reported third-quarter 2019 earnings of $3.60 per share, in line with the street projection. —...
Stryker (SYK): Q3 2019 Earnings Snapshot
— Stryker (NYSE: SYK) reported third-quarter 2019 earnings of $1.91 per share, vs. $1.90 per share expected. — Total revenue...
Amgen beats in Q3, raises guidance
Amgen Inc (NASDAQ: AMGN) reported third-quarter 2019 adjusted EPS of $3.66 on revenue of $5.74 billion. This was better than...
Pfizer (PFE) reports better-than-expected Q3 results; stock gains
Drugmaker Pfizer (NYSE: PFE) reported lower revenues and earnings for the third quarter. The results, however, topped the market’s expectations....
Merck’s (MRK) Q3 results beat estimates; sales boosted by oncology and vaccines
Merck (NYSE: MRK) surpassed analysts’ expectations for revenue and earnings in the third quarter of 2019, sending the shares climbing...
Walgreens Boots (WBA) earnings preview: No surprises expected in Q4 report
It has been a tough year for Walgreens Boots Alliance (NASDAQ: WBA) so far, with the stock losing steadily amid...
Gilead Sciences, Inc (GILD): Q3 2019 Earnings Snapshot
— Gilead Sciences (NYSE: GILD) reported third-quarter 2019 earnings of $1.75 per share, vs. $1.74 per share expected. — Total...
Baxter International Inc. (BAX) Q3 2019 Earnings Snapshot
— Baxter International Inc. (NYSE: BAX) reported third-quarter 2019 revenues of $2.85 billion, up 3% YoY, vs. $2.86 billion expected....